| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |